71
Views
27
CrossRef citations to date
0
Altmetric
Original Research

LincRNA-p21 leads to G1 arrest by p53 pathway in esophageal squamous cell carcinoma

, , , , , , & show all
Pages 6201-6214 | Published online: 04 Jul 2019

References

  • Shang L, Liu HJ, Hao JJ, et al. A panel of overexpressed proteins for prognosis in esophageal squamous cell carcinoma. PLoS One. 2014;9(10):e111045. doi:10.1371/journal.pone.011104525337715
  • Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.00619239885
  • Caley DP, Pink RC, Trujillano D, Carter DRF. Long noncoding RNAs, chromatin, and development. Sci World Jo. 2010;10:90–102. doi:10.1100/tsw.2010.7
  • Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):U1071–U1148. doi:10.1038/nature08975
  • Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of Histone modification complexes. Science. 2010;329(5992):689–693. doi:10.1126/science.119200220616235
  • Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346. doi:10.1038/nature1088722337053
  • Wang XY, Li M, Wang ZQ, et al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem. 2015;290(7):3925–3935. doi:10.1074/jbc.M114.59686625538231
  • Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041. doi:10.1038/sj.onc.120692812970751
  • Hao YB, Wu W, Shi FC, et al. Prediction of long noncoding RNA functions with co-expression network in esophageal squamous cell carcinoma. BMC Cancer. 2015;15:ARTN 168. doi:10.1186/s12885-015-1584-3
  • Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Patho. 2014;7(11):7938–7944.
  • Pan F, Yao J, Chen Y, et al. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Patho. 2014;7(6):2838–2849.
  • Wang CM, Wu QQ, Li SQ, et al. Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Digest Dis Sci. 2014;59(3):591–597. doi:10.1007/s10620-013-2956-724337686
  • Li X, Wu Z, Mei Q, et al. Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma. Brit J Cancer. 2013;109(8):2266–2278. doi:10.1038/bjc.2013.54824022190
  • Lv XB, Lian GY, Wang HR, Song EW, Yao HR, Wang MH. Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One. 2013;8(5):ARTN e63516. doi:10.1371/journal.pone.0063516
  • Chen FJ, Sun M, Li SQ, et al. Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis. Mol Carcinogen. 2013;52(11):908–915. doi:10.1002/mc.21944
  • Li W, Zheng J, Deng JQ, et al. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Gastroenterology. 2014;146(7):1714–1726. doi:10.1053/j.gastro.2014.03.00224631494
  • Yang X, Song JH, Cheng YL, et al. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 2014;63(6):881–890. doi:10.1136/gutjnl-2013-30526624000294
  • Chen DY, Zhang ZY, Mao CM, et al. ANRIL inhibits p15(INK4b) through the TGF beta 1 signaling pathway in human esophageal squamous cell carcinoma. Cell Immunol. 2014;289(1–2):91–96. doi:10.1016/j.cellimm.2014.03.01524747824
  • Huarte M, Guttman M, Feldser D, et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010;142(3):409–419. doi:10.1016/j.cell.2010.06.04020673990
  • Ying Z, Yue M, Yuhong Z, Ran L, Yuepu P, Lihong Y. Mechanism of inhibition of esophageal cancer cell proliferation by lincRNA-p21. Environ Occup Med. 2018;35(06):479–484.
  • Xiajun L, Miao Y, Zicheng D, Ran L, Lihong Y, Yuepu P. Preliminary study on the risk of lncRNA-UCA1 and huaian esophageal cancer. Cancer Aberration Mutat. 2014;26(06):407–411.
  • Yoon JH, Abdelmohsen K, Srikantan S, et al. LincRNA-p21 suppresses target mRNA translation. Mol Cell. 2012;47(4):648–655. doi:10.1016/j.molcel.2012.06.02722841487
  • Dimitrova N, Zamudio JR, Jong RM, et al. LincRNA-p21 activates p21 in cis to promote polycomb target gene expression and to enforce the G1/S checkpoint. Mol Cell. 2014;54(5):777–790. doi:10.1016/j.molcel.2014.04.02524857549
  • Jia M, Jiang L, Wang YD, Huang JZ, Yu M, Xue HZ. LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling-induced epithelial-mesenchymal transition. Hepatol Res. 2016;46(11):1137–1144. doi:10.1111/hepr.1265927391793
  • Zhai HY, Fesler A, Schee K, Fodstad O, Flatmark K, Ju JF. Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Canc. 2013;12(4):261–266. doi:10.1016/j.clcc.2013.06.003
  • Wang GY, Li ZW, Zhao Q, et al. LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/beta-catenin signaling pathway. Oncol Rep. 2014;31(4):1839–1845. doi:10.3892/or.2014.304724573322
  • Castellano JJ, Navarro A, Vinolas N, et al. LincRNA-p21 impacts prognosis in resected non-small cell lung cancer patients through angiogenesis regulation. J Thorac Oncol. 2016;11(12):2173–2182. doi:10.1016/j.jtho.2016.07.01527496652
  • Hall JR, Messenger ZJ, Tam HW, Phillips SL, Recio L, Smart RC. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis. 2015;6:ARTN e1700. doi:10.1038/cddis.2015.67
  • Isin M, Ozgur E, Cetin G, et al. Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014;431:255–259. doi:10.1016/j.cca.2014.02.01024583225
  • Ozkan TA. Re: exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. J Urol Surg. 2015;2(4):201. doi:10.4274/jus.2015.04.002
  • Li XY, Pu JX, Jiang SY, et al. Henryin, an ent-kaurane diterpenoid, inhibits wnt signaling through interference with beta-catenin/TCF4 interaction in colorectal cancer cells. PLoS One. 2013;8(7):ARTN e68525. doi:10.1371/journal.pone.0068525
  • Yang N, Fu Y, Zhang HB, Sima H, Zhu N, Yang GS. LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma. Oncotarget. 2015;6(29):28151–28163. doi:10.18632/oncotarget.466126305675
  • Wu GZ, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014;130(17):1452–U1464. doi:10.1161/CIRCULATIONAHA.114.01167525156994
  • Zhou WQ, Wang P, Shao QP, Wang J. Lipopolysaccharide promotes pulmonary fibrosis in acute respiratory distress syndrome (ARDS) via lincRNA-p21 induced inhibition of Thy-1 expression. Mol Cell Biochem. 2016;419(1–2):19–28. doi:10.1007/s11010-016-2745-727392907
  • Spurlock CF 3rd, Tossberg JT, Matlock BK, Olsen NJ, Aune TM. Methotrexate inhibits NF-kappaB activity via long intergenic (noncoding) RNA-p21 induction. Arthritis Rheumatol. 2014;66(11):2947–2957. doi:10.1002/art.3880525077978
  • Yang F, Zhang HF, Mei YD, Wu M. Reciprocal regulation of HIF-1 alpha and lincRNA-p21 modulates the Warburg effect. Mol Cell. 2014;53(1):88–100. doi:10.1016/j.molcel.2013.11.00424316222
  • Wang J, Lei ZJ, Guo Y, et al. miRNA-regulated delivery of lincRNA-p21 suppresses beta-catenin signaling and tumorigenicity of colorectal cancer stem cells. Oncotarget. 2015;6(35):37852–37870. doi:10.18632/oncotarget.563526497997
  • Işın, M, Uysaler E, Özgür, E, et al. Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease. Front Genet. 2015;6. doi:10.3389/fgene.2015.00360
  • Recio L, Phillips SL, Maynor T, Waters M, Jackson AF, Yauk CL. Differential expression of long noncoding RNAs in the livers of female B6C3F1 mice exposed to the carcinogen furan. Toxicol Sci. 2013;135(2):369–379. doi:10.1093/toxsci/kft15323853263
  • Chou SD, Murshid A, Eguchi T, Gong J, Calderwood SK. HSF1 regulation of beta-catenin in mammary cancer cells through control of HuR/elavL1 expression. Oncogene. 2015;34(17):2178–2188. doi:10.1038/onc.2014.17724954509
  • Bao XC, Wu HT, Zhu XH, et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res. 2015;25(1):80–92. doi:10.1038/cr.2014.16525512341
  • Li RQ, Ren YL, Liu WJ, Pan WT, Xu FJ, Yang M. MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors. Nanoscale. 2017;9(7):2521–2530. doi:10.1039/c6nr09668a28150831
  • Wang XH, Gao ZK, Liao J, et al. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway. J Toxicol Env Heal A. 2016;79(9–10):407–418. doi:10.1080/15287394.2016.1176617
  • Hu HB, Jie HY, Zheng XX. Three circulating LncRNA predict early progress of esophageal squamous cell carcinoma. Cell Physiol Biochem. 2016;40(1–2):117–125. doi:10.1159/00045252927855375
  • Xia WZ, Zhuang L, Hou M. Role of lincRNA-p21 in the protective effect of macrophage inhibition factor against hypoxia/serum deprivation-induced apoptosis in mesenchymal stem cells. Int J Mol Med. 2018;42(4):2175–2184. doi:10.3892/ijmm.2018.376730015822
  • Ye YY, He XZ, Lu FF, et al. A lincRNA-p21/miR-181 family feedback loop regulates microglial activation during systemic LPS-and MPTP-induced neuroinflammation. Cell Death Dis. 2018;9:ARTN 803. doi:10.1038/s41419-018-1111-y
  • Vazquez A, Bond EE, Levine AJ, Bond GL. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov. 2008;7:979. doi:10.1038/nrd265619043449
  • Suk FM, Chang CC, Lin RJ, et al. ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner. Sci Rep-Uk. 2018;8:ARTN 2742. doi:10.1038/s41598-018-21160-z
  • Zhang Y, Yan B. Cell cycle regulation by carboxylated multiwalled carbon nanotubes through p53-independent induction of p21 under the control of the BMP signaling pathway. Chem Res Toxicol. 2012;25(6):1212–1221. doi:10.1021/tx300059m22428663